Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rejuvenated and washed autologous red blood cells are an investigational **autologous blood-product transfusion intervention** studied by Duke University in healthy volunteers with donation-induced anemia. A participant's stored red blood cell unit is incubated ex vivo with Rejuvesol red blood cell processing solution, then washed before intravenous reinfusion. Rejuvenation restores red-cell 2,3-diphosphoglycerate and adenosine triphosphate depleted during storage, increasing hemoglobin p50 toward normal and improving oxygen unloading to tissues. In the Duke pilot study NCT03089047, the intervention was evaluated against standard stored autologous red blood cell transfusion using maximal oxygen uptake as a physiologic measure of oxygen-delivery benefit. ([cdn.clinicaltrials.gov](https://cdn.clinicaltrials.gov/large-docs/47/NCT03089047/Prot_SAP_000.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rejuvenated and washed autologous red blood cells.